Telomere dysfunction and telomerase reactivation in the etiology and progression of liver cancer
Description: NARRATIVE Mutations in telomerase and telomere dysfunction are implicated in the pathogenesis of a growing number of human disorders, including end-stage liver disease and cancer. In this proposal, we will determine the molecular mechanisms behind hepatic cell failure and transformation in settings of impaired telomerase, and elucidate new pathways involved in the progression of this response after telomere damage. We will use a unique combination of molecular and cellular models to significantly increase current knowledge on hepatocyte function and transformation in settings of short telomeres, DNA damage, and mutant telomerase.
Funder: National Cancer Institute
Funding type: research
Funder scheme: R01
Start date: 2021-12-13
End date: 2026-11-30
Investigator: LUIS FRANCISCO ZIRNBERGER BATISTA (lead)
Institutions: Washington University in St. Louis, WASHINGTON UNIVERSITY
Subfield: Cell Biology
Domain: Life Sciences
Funded outputs count: 6
Funder award ID: R01CA258386
OpenAlex ID: G9000878878
